Georg Winter
18Patents
8h-index
13Co-inventors
61Inventor score
Filing activity: May 8, 2015 → Nov 12, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9821068B2 | Methods to induce targeted protein degradation through bifunctional molecules | Emerging Cross-Sectional Technologies | 51 | Active |
| US9694084B2 | Methods to induce targeted protein degradation through bifunctional molecules | Emerging Cross-Sectional Technologies | 48 | Active |
| US9750816B2 | Methods to induce targeted protein degradation through bifunctional molecules | Emerging Cross-Sectional Technologies | 48 | Active |
| US10125114B2 | Methods to induce targeted protein degradation through bifunctional molecules | Chemistry; Metallurgy | 43 | Active |
| US9770512B2 | Methods to induce targeted protein degradation through bifunctional molecules | Emerging Cross-Sectional Technologies | 43 | Active |
| US10464925B2 | Methods to induce targeted protein degradation through bifunctional molecules | Chemistry; Metallurgy | 21 | Active |
| US10849980B2 | Methods to induce targeted protein degradation through bifunctional molecules | Emerging Cross-Sectional Technologies | 12 | Active |
| US10669253B2 | Methods to induce targeted protein degradation through bifunctional molecules | Chemistry; Metallurgy | 12 | Active |
| US11583586B2 | Methods to induce targeted protein degradation through bifunctional molecules | Emerging Cross-Sectional Technologies | 3 | Active |
| US11059801B2 | Methods to induce targeted protein degradation through bifunctional molecules | Chemistry; Metallurgy | 2 | Active |
| US11311609B2 | Regulating chimeric antigen receptors | Chemistry; Metallurgy | 1 | Active |
| US12023385B2 | Tunable endogenous protein degradation with heterobifunctional compounds | Chemistry; Metallurgy | 0 | Active |
| US10925868B2 | Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12410152B2 | Oxazole and thioazole-type cullin ring ubiquitin ligase compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11293023B2 | Tunable endogenous protein degradation | Chemistry; Metallurgy | 0 | Active |
| US11578075B2 | Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11046954B2 | Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses | Chemistry; Metallurgy | 0 | Active |
| US10899768B2 | Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.